Inventor
DESJARDIN MICHAEL A
US31 patents
⚠️ This page may combine multiple inventors who share the name “DESJARDIN MICHAEL A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INTARCIA THERAPEUTICS INC
10 patentsUS8992962B2Mar 31, 2015
Two-piece, internal-channel osmotic delivery system flow modulator
INTARCIA THERAPEUTICS INC29 citations97
US7879028B2Feb 1, 2011
Osmotic delivery systems and piston assemblies for use therein
INTARCIA THERAPEUTICS INC72 citations97
US7682356B2Mar 23, 2010
Osmotic delivery systems and piston assemblies for use therein
INTARCIA THERAPEUTICS INC84 citations97
US8367095B2Feb 5, 2013
Two-piece, internal-channel osmotic delivery system flow modulator
INTARCIA THERAPEUTICS INC33 citations96
US8052996B2Nov 8, 2011
Two-piece, internal-channel osmotic delivery system flow modulator
INTARCIA THERAPEUTICS INC37 citations96
US9095553B2Aug 4, 2015
Solvent/polymer solutions as suspension vehicles
INTARCIA THERAPEUTICS INC27 citations95
US9526763B2Dec 27, 2016
Solvent/polymer solutions as suspension vehicles
INTARCIA THERAPEUTICS INC24 citations93
US9539200B2Jan 10, 2017
Two-piece, internal-channel osmotic delivery system flow modulator
INTARCIA THERAPEUTICS INC23 citations91
US7655254B2Feb 2, 2010
Implantable device for continuous delivery of interferon
INTARCIA THERAPEUTICS INC44 citations89
US10527170B2Jan 7, 2020
Osmotic delivery systems and piston assemblies for use therein
INTARCIA THERAPEUTICS INC0 citations52
ROHLOFF CATHERINE M
5 patentsUS8114437B2Feb 14, 2012
Solvent/polymer solutions as suspension vehicles
ROHLOFF CATHERINE M42 citations97
US8460694B2Jun 11, 2013
Solvent/polymer solutions as suspension vehicles
ROHLOFF CATHERINE M26 citations95
US8440226B2May 14, 2013
Solvent/polymer solutions as suspension vehicles
ROHLOFF CATHERINE M29 citations95
US8211467B2Jul 3, 2012
Osmotic drug delivery devices containing suspension formulations comprising particles having active agents and nonaqueous single-phase vehicles
ROHLOFF CATHERINE M36 citations95
US8206745B2Jun 26, 2012
Solvent/polymer solutions as suspension vehicles
ROHLOFF CATHERINE M38 citations95
ALZA CORP
4 patentsUS6491683B1Dec 10, 2002
Osmotic dosage form composed of an extruded polymer tube form
ALZA CORP66 citations96
US6630165B2Oct 7, 2003
Methods for providing effective reboxetine therapy with once-a-day dosing
ALZA CORP27 citations90
US6387403B1May 14, 2002
Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing
ALZA CORP18 citations90
US7772182B2Aug 10, 2010
Stable suspension formulations of erythropoietin receptor agonists
ALZA CORP4 citations58
LAUTENBACH SCOTT D
3 patentsUS8470353B2Jun 25, 2013
Two-piece, internal-channel osmotic delivery system flow modulator
LAUTENBACH SCOTT D31 citations95
US8273365B2Sep 25, 2012
Two-piece, internal-channel osmotic delivery system flow modulator
LAUTENBACH SCOTT D33 citations95
US8158150B2Apr 17, 2012
Two-piece, internal-channel osmotic delivery system flow modulator
LAUTENBACH SCOTT D35 citations95
DOW CHEMICAL CO
3 patentsUS4782161ANov 1, 1988
Preparation of fluoropyridines
DOW CHEMICAL CO2 citations63
US4713460ADec 15, 1987
2,3-bis-(poly)(chloromethyl)pyridines
DOW CHEMICAL CO5 citations62
US4785112ANov 15, 1988
Process for the production of 2,3,5,6-tetrachloropyridine and 2,3,6-trichloropyridine
DOW CHEMICAL CO3 citations54